Biopharmaceutical company UCB (Euronext Brussels:UCB) and Domino Data Lab, a data science platform provider, announced on Monday a strategic collaboration aimed at modernising a Statistical Computing Environment (SCE) for the life sciences industry.

The partnership aims to convert legacy SCE into unified, scalable and flexible platforms to meet the evolving demands of clinical research, regulatory compliance and efficient data analysis.

UCB and Domino Data Lab plan to implement a modern cloud-enabled environment that integrates diverse analytical tools, such as SAS, R and Python, within a unified framework, using Domino's expertise in cloud technologies and open-source support combined with UCB's clinical research and regulatory expertise.

This is intended to enhance research capabilities and maintain compliance with industry standards like GxP, FDA 21 CFR Part 11 and GDPR.